| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |